Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment

Locally advanced or metastatic urothelial bladder cancer (a/m UBC) is currently treated using platinum-based combination chemotherapy. Immune checkpoint inhibitors (ICIs) are the preferred second-line treatment options for cisplatin-eligible a/m UBC patients and as first-line options in cisplatin-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Won, Seo, Ho Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431699/
https://www.ncbi.nlm.nih.gov/pubmed/34502435
http://dx.doi.org/10.3390/ijms22179526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431699/
https://www.ncbi.nlm.nih.gov/pubmed/34502435
http://dx.doi.org/10.3390/ijms22179526

Ejemplares similares